Cardiology Department, AP-HP, Bichat University Hospital, 46 rue Henri Huchard, Paris 75018, France.
Eur Heart J. 2013 Jul;34(25):1923-30. doi: 10.1093/eurheartj/eht097. Epub 2013 Mar 20.
We analysed reinterventions performed during long-term follow-up after percutaneous mitral commissurotomy (PMC) with a particular focus on freedom from mitral surgery and late results of repeat PMC.
In 912 patients who had good immediate results of PMC (valve area ≥1.5 cm² with mitral regurgitation ≤2/4), we analysed survival without reintervention (surgery or repeat PMC) and survival without surgery alone, with a follow-up up to 20 years. The median age was 48 years, and 251 patients (27%) had calcified valves. During a median follow-up of 12 years, 351 patients (38%) underwent a reintervention: surgery was performed in 266 (76%) patients and repeat PMC in 85 (24%). Cardiovascular survival without reintervention (surgery or repeat PMC) was 38 ± 2% at 20 years. When analysing cardiovascular survival without surgery, this rate increased to 46 ± 2% at 20 years. In the 504 patients aged <50 years at the time of their initial PMC, 20-year rates were 45 ± 3% for cardiovascular survival without reintervention and 57 ± 3% for cardiovascular survival without surgery. Of the 85 patients who underwent repeat PMC, cardiovascular survival without surgery was 60 ± 7% at 10 years.
After successful PMC, reintervention is frequently needed. However, almost half of the patients remained free from surgery at 20 years. Repeat PMC was performed in one out of four cases of reintervention in this study, thereby allowing for postponement of surgery in a substantial number of patients.
我们分析了经皮二尖瓣交界切开术(PMC)后长期随访期间的再次介入治疗,特别关注二尖瓣手术的无复发率和再次 PMC 的晚期结果。
在 912 例 PMC 即时效果良好的患者(瓣口面积≥1.5cm²且二尖瓣反流≤2/4)中,我们分析了无再次介入(手术或再次 PMC)和无单纯手术的生存情况,并随访了长达 20 年。患者的中位年龄为 48 岁,251 例(27%)患者有钙化瓣膜。在中位随访 12 年后,351 例患者(38%)接受了再次介入治疗:266 例(76%)患者行手术治疗,85 例(24%)患者行再次 PMC。无再次介入(手术或再次 PMC)的心血管生存率在 20 年时为 38±2%。分析无手术的心血管生存率时,这一比率在 20 年时增加到 46±2%。在初始 PMC 时年龄<50 岁的 504 例患者中,无再次介入的心血管生存率为 20 年时 45±3%,无手术的心血管生存率为 57±3%。在再次接受 PMC 的 85 例患者中,无手术的心血管生存率在 10 年时为 60±7%。
成功进行 PMC 后,再次介入治疗常常是必需的。然而,在 20 年时几乎有一半的患者无需手术。在本研究中,再次介入治疗中有四分之一的患者需要再次 PMC,从而使大量患者能够推迟手术。